These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 781664)

  • 1. [Significance of autotransplantation of bone marrow in the restoration of hematopoiesis in oncological patients being treated with sarcolysin].
    Zhukovskiĭ IIa
    Probl Gematol Pereliv Krovi; 1975 Dec; 20(12):33-6. PubMed ID: 781664
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stimulating effect of autotransplantation of preserved bone marrow on hematopoiesis].
    Kovalenko PP; Baĭdaev AB
    Vestn Khir Im I I Grek; 1975 Apr; 114(4):56-9. PubMed ID: 772940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission.
    Michel G; Maraninchi D; Demeocq F; Perrimond H; Blaise D; Gaspard MH; Stoppa AM; Gastaut JA; Lepeu G; Novakovitch G
    Bone Marrow Transplant; 1988 Mar; 3(2):105-11. PubMed ID: 3048474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro and in vivo recovery of marrow progenitor cells after cryopreservation and autotransplantation of the bone marrow].
    Dragani A; Iacone A; Accorsi P; Angelini A; Di Girolamo G; Geraci L; Berardi A; D'Antonio D; Di Bartolomeo P; Cacciafiori G
    Boll Soc Ital Biol Sper; 1987 Mar; 63(3):217-24. PubMed ID: 3307836
    [No Abstract]   [Full Text] [Related]  

  • 5. Acceleration of hemopoietic recovery after autologous bone marrow transplantation by low doses of peripheral blood stem cells.
    Lopez M; Mortel O; Pouillart P; Zucker JM; Fechtenbaum J; Douay L; Palangie T; Michon J; Salmon D; Gorin NC
    Bone Marrow Transplant; 1991 Mar; 7(3):173-81. PubMed ID: 1676321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Ewing's sarcoma with high-dose melphalan and autologous bone marrow transplantation.
    Cornbleet MA; Corringham RE; Prentice HG; Boesen EM; McElwain TJ
    Cancer Treat Rep; 1981; 65(3-4):241-4. PubMed ID: 7016319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts.
    Rowley SD; Piantadosi S; Marcellus DC; Jones RJ; Davidson NE; Davis JM; Kennedy J; Wiley JM; Wingard JR; Yeager AM
    Bone Marrow Transplant; 1991 Mar; 7(3):183-91. PubMed ID: 2059755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hematopoiesis after autotransplantation of preserved bone marrow in patients receiving chemotherapy].
    Lavrik SS; Baksheeva AA; Zverkova AS
    Vrach Delo; 1965 Dec; 12():61-5. PubMed ID: 5334559
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete regression of osteogenic sarcoma scalp metastases following one pulse of high-dose melphalan combined with a bone marrow autograft: case report.
    Mauger DC
    N Z Med J; 1982 Jul; 95(711):455-6. PubMed ID: 7050786
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged survival in disseminated seminoma treated to aplasia by wide field X--radiotherapy and phenylalanine mustine with autologous bone marrow cell transfusion cover.
    Humble JG; Newton KA; Mellor H; Pegg DE
    Clin Oncol; 1975 Sep; 1(3):235-8. PubMed ID: 765039
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autologous bone marrow transplantation in pediatric cancer].
    Ohira M
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2299-306. PubMed ID: 2260867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival.
    Körbling M; Fliedner TM; Holle R; Magrin S; Baumann M; Holdermann E; Eberhardt K
    Bone Marrow Transplant; 1991 May; 7(5):343-9. PubMed ID: 1676924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654].
    Urban C; Slace I; Kaulfersch W; Greinix H; Höcker P
    Padiatr Padol; 1986; 21(3):275-82. PubMed ID: 3534689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of the viability of preserved bone marrow in transplantation to oncological patients].
    Ostankova LV; Shenberg MG; Pushkar' NS
    Ortop Travmatol Protez; 1971 May; 32(5):43-7. PubMed ID: 4947679
    [No Abstract]   [Full Text] [Related]  

  • 15. GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia.
    Sureda A; Canals C; Badell I; Nomdedeu J; Llácer M; Brunet S; Sierra J; Grañena A; Cubells J; Domingo-Albós A
    Prog Clin Biol Res; 1992; 377():315-20. PubMed ID: 1438428
    [No Abstract]   [Full Text] [Related]  

  • 16. [Autologous bone marrow transplantation in solid tumors in children].
    Ohira M; Shibata T; Ise T
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1428-37. PubMed ID: 6347080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new therapeutic method for malignant cancer is tested in Lund. It is possible to give extreme doses of melphalan because of the autologous bone marrow transplantation].
    Lennholm B
    Lakartidningen; 1982 Dec; 79(48):4527-8. PubMed ID: 6761518
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematologic recovery following autologous and allogeneic bone marrow transplantation.
    Harada M; Yoshida T; Ishino C; Matsue K; Kodo H; Mori T; Shiobara S; Odaka K; Ohtake S; Kondo K
    Exp Hematol; 1983 Oct; 11(9):841-8. PubMed ID: 6357827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.
    Roodman GD; LeMaistre CF; Clark GM; Page CP; Newcomb TF; Knight WA
    Bone Marrow Transplant; 1987 Aug; 2(2):165-73. PubMed ID: 3332164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of advanced Hodgkin's disease with high dose melphalan and autologous bone marrow transplantation.
    Russell JA; Selby PJ; Ruether BA; Mbidde EK; Ashley S; Zulian G; Berry J; Houwen B; Jones AR; Poon MC
    Bone Marrow Transplant; 1989 Jul; 4(4):425-9. PubMed ID: 2673463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.